The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...

Grifols, already the largest private employer in Johnston County, is about to get even bigger. The Spanish biotherapeutics company is investing $210 million in two new facilities at its manufacturing ...

Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...

The North Carolina Biotechnology Center has awarded a $30,000 low-interest Company Inception Loan to a young Asheville medical therapeutics company, Venafair. Vascular surgeon Richard Bock, founder of ...

North Carolina is one of five states consistently recognized for its specialized life science industry. The state’s strong network of life science companies, universities and skilled workforce provide ...

Durham-based Qualyst Transporter Systems (QTS) has launched a new test that can steer drug developers away from compounds that could cause liver damage. The company’s latest lab assay is a novel way ...

Research Triangle Park-based Talecris Biotherapeutics continues to notch news-making successes, with a new marketing approval from the U.S. Food and Drug Administration for a more potent formulation ...

It isn't because he's so successful at avoiding rivalries by holding concurrent professorships at the University of North Carolina at Chapel Hill and North Carolina State University. Joseph DeSimone, ...

Avery County is known for its beautiful Appalachian slopes, including Grandfather Mountain, and for its production of Fraser fir Christmas trees. But a grant from the North Carolina Biotechnology ...

An incubator formed to build companies from Duke University medical technologies and an incubator for oysters are among 26 semi-finalists from across North Carolina vying for the spring 2016 round of ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...